Form 4 for RDHL RedHill Biopharma Ltd.
Accepted 2026-07-13 16:03:03 ET · period of report 2026-07-10 · accession 0001178913-26-003473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-13 16:03 | 2026-07-10 | RDHL | Raday Gilead | COO | S - Sale | $0.0001 | -14.13M | 218.78M | -6% | -$1,413 |
| D | 2026-07-13 16:03 | 2026-07-10 | RDHL | Raday Gilead | COO | M - OptEx | $0.00 | +28.15M | 104.13M | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-10 | S | D | 14,130,000 | $0.0001 | 218,780,000 | D | — | — | (F1) The reporting person sold 1,413 American Depositary Shares ("ADS") of RedHill Biopharma Inc. (the "Issuer"), each ADS represents 10,000 ordinary shares, par value NIS 0.01 per share, solely to satisfy tax withholding obligations incurred upon the vesting of an aggregate of 4,228 restricted share units granted to him on July 1, 2023, June 24, 2024, March 26, 2025 and January 23, 2026. Such transaction was effected by the trustee appointed in accordance with the regulations set by the Israeli Tax Authority pursuant to a sell to cover policy and does not represent a discretionary trade by the reporting person. (F1) The reporting person sold 1,413 American Depositary Shares ("ADS") of RedHill Biopharma Inc. (the "Issuer"), each ADS represents 10,000 ordinary shares, par value NIS 0.01 per share, solely to satisfy tax withholding obligations incurred upon the vesting of an aggregate of 4,228 restricted share units granted to him on July 1, 2023, June 24, 2024, March 26, 2025 and January 23, 2026. Such transaction was effected by the trustee appointed in accordance with the regulations set by the Israeli Tax Authority pursuant to a sell to cover policy and does not represent a discretionary trade by the reporting person. (F2) The price reported in Table I Column 4 is $0.6973 per ADS, which would be equivalent to $0.00006973 per ordinary share. |
| 2 | Derivative | American Depositary Shares | 2026-07-10 | M | A | 28,150,000 | $0.00 | 104,130,000 | D | — · — to — | 28,150,000 Ordinary Shares | (F3) Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date. (F3) Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date. (F3) Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date. |